focus -WSS

focus

author：knowledge 2025-10-02 00:19:00 - browse：1

3D dollar signs come out of a prescription drug bottle — coverage from STAT — Adobe

WASHINGTON — Venture capitalists are still pouring money into drug research in spite of Medicare’s new power to negotiate drug prices, according to Congress’ nonpartisan budget experts.

The Inflation Reduction Act includes two measures that directly lower drug prices. Medicare price negotiation is the most controversial of the two. The law gives drugs 9 years on the market before negotiated prices take effect; biologics get 13 years. Drugs are selected for negotiation among the 50 top-selling drugs without generic or biosimilar competition. Medicare will negotiate prices for 10 drugs to start. Up to 60 drugs will be subject to negotiation over the next four years, and up to 20 more drugs every year afterward.

The law also requires drug companies to pay back Medicare when they raise prices on drugs faster than inflation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Change Healthcare: What is it, why does its cyberattack matter?

knowledge

WSS

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Police still searching for prisoner who escaped from NYC hospital

Medicare drug price negotiation continues, as pharma counteroffers

In same hospitals, Black patients receive fewer opioids than white patients

A new approach to psychiatric drug development

NIH trials fail to test meaningful long Covid therapies, experts say

explore

focus

hotspot

Jerome Adams on the need for new antivirals for Covid

Harvard's David Sinclair gets blowback over aging

Hepatitis C has a cure — but many Americans still lack access to it

Harvard's David Sinclair gets blowback over aging

Sports medicine is finally prioritizing gender equality

NIH trials fail to test meaningful long Covid therapies, experts say

Moonlake's readout produced a cash windfall. Risks remain

Naloxone nonprofit donates 200,000 doses after FDA approval

Affirmative action in medical school literally saved lives

What to know about Virgin Galactic's 1st mission taking paying customers to space

hotspot

FDA panel issues narrow recommendation for Covid vaccine booster doses

Streamlined flu vaccines recommended by FDA advisory panel

Why Talkspace is targeting Medicare, a tricky market

Ozempic has benefits for kidney disease as well as diabetes

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

knowledge

focus

focus

hotspot